Betaxolol: A comprehensive profile

Area of Science:

• Pharmacology
• Analytical Chemistry

Background:

• Betaxolol is a cardioselective beta-1 adrenergic receptor antagonist.
• It possesses no intrinsic sympathomimetic activity and weak local anesthetic properties.
• Betaxolol reduces cardiac output, lowers blood pressure, and decreases intraocular pressure (IOP) by inhibiting aqueous humor secretion.

Purpose of the Study:

• To provide a comprehensive review of betaxolol.
• To cover nomenclature, physicochemical properties, preparation, and analytical techniques.
• To discuss the pharmacology and enantiomeric separation of betaxolol.

Main Methods:

• Review of existing literature on betaxolol.
• Analysis of qualitative and quantitative techniques for betaxolol.
• Examination of chromatographic methods for enantiomeric separation.

Main Results:

• Betaxolol selectively blocks beta-1 adrenergic receptors, reducing cardiac activity and blood pressure.
• Topical ocular application lowers intraocular pressure.
• The (S)-(-)-enantiomer demonstrates superior pharmacological activity.
• Various analytical and chromatographic methods for betaxolol characterization and separation are detailed.

Conclusions:

• Betaxolol is a valuable cardioselective beta-blocker with applications in cardiovascular and ophthalmic conditions.
• Understanding its properties and analytical methods is crucial for effective use.
• Enantiomeric separation techniques are important for optimizing betaxolol's therapeutic potential.